Niš-based company Neomedica opens a factory in Cairo

Neomedica has successfully started the production of hematological reagents at its newly constructed factory in Cairo. In the last week of February, the production of the zero series of reagents was launched, marking an important step in establishing production capacities to support the healthcare sector of Egypt and the broader region of North Africa and the Middle East.

The newly built factory in Egypt has a production capacity that is four times larger than the capacity of its parent factory in Serbia. This significant capacity not only allows for the expansion of supplies to Egypt’s healthcare system but also enables export activities to surrounding countries in North Africa and the Middle East, contributing to regional development and improving healthcare services.

All production capacities of the factory have been fully installed and are operational. Extensive training and education programs for employees have been carried out, ensuring they are fully prepared for independent production.

Additionally, specialized quality control personnel have undergone training and work in synchronization with the quality control team in Serbia, ensuring the achievement of the highest quality standards in every segment of production.

Neomedica fully controls the production of hematological reagents, as well as the quality of products at its facility in Egypt. All production processes are carried out under strict supervision and in compliance with global standards, ensuring top-tier results and safety for end users.

In February 2024, Neomedica signed a tripartite agreement with the company El Hoda and the Egyptian government agency UPA (The Egyptian Authority for Unified Procurement and Medical Supply) to launch its production of hematological reagents in Egypt. This Serbian company has been supplying Egypt’s healthcare sector since 2016.

Photo: Neomedica